| Description |
1 online resource (x, 107 pages) : illustrations |
| Contents |
Cover -- Pharmacoeconomics in Psychiatry -- Contents -- About the contributors -- Preface -- 1 Pharmacoeconomic evaluation and psychiatry -- Economics: topic and discipline -- Needs, services and scarcity -- Criteria for choice and evaluation -- A framework for evaluation -- Cost-effectiveness and other evaluations -- Putting principles into practice -- Conclusions -- References -- 2 Schizophrenia -- The data -- Clozapine versus typical antipsychotic agents -- Risperidone versus typical antipsychotics -- Olanzapine -- Quetiapine -- Amisulpride -- Zotepine -- 'Head-to-head' comparisons of atypical antipsychotic drugs -- Conclusion -- Search details -- References -- 3 Depression -- Types of cost -- Types of pharmacoeconomic analysis -- Evidence for differences in pharmacoeconomic outcomes -- Other issues -- Comment -- References -- 4 Anxiety disorders -- Anxiety disorders -- Specific disorders -- Conclusion -- References -- 5 Bipolar affective disorder -- Treatment -- Economic impact of bipolar disorder -- Discussion -- Acknowledgement -- References -- 6 Dementia: evidence and issues -- Methods of pharmacoeconomics -- Review of the evidence -- Conclusion -- Search details -- References -- 7 Evidence and practice -- Schizophrenia -- Depression and bipolar disorder -- Dementia -- Anxiety disorders -- Conclusion -- References -- Index |
| Summary |
Pharmacoeconomics is a new word but decisions about which treatments are available within any health care system have always been influenced by the availability of resources. Today, the economics of care and treatment are major issues for governments and health services throughout the world. This is the first text to provide an authoritative economic evaluation of the use of drugs in psychiatry. The authors have reviewed the world literature on the subject and include all the most recent data. The book provides pragmatic but scientifically robust reviews of the pharmacoeconomic aspects of drug prescribing in order to improve clinical practice. With the ultimate aim of ensuring that resources are used to the best effect and thus improve the health and quality of life of people with mental health problems, this practical handbook is an important text for psychiatrists and GPs, as well as for health service providers and managers |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Psychotropic drugs -- Cost effectiveness
|
|
Medical economics.
|
|
Cost effectiveness.
|
|
Drugs -- Cost effectiveness
|
|
Psychopharmacology -- Economic aspects
|
|
Drugs -- Prescribing -- Economic aspects
|
|
Psychotropic Drugs -- economics
|
|
Economics, Medical
|
|
Cost-Benefit Analysis
|
|
cost benefit analysis.
|
|
MEDICAL -- Pain Medicine.
|
|
MEDICAL -- Psychiatry -- Psychopharmacology.
|
|
Drugs -- Prescribing -- Economic aspects
|
|
Drugs -- Cost effectiveness
|
|
Cost effectiveness
|
|
Medical economics
|
| Form |
Electronic book
|
| Author |
Taylor, David, 1963-
|
|
Knapp, Martin (Martin R. J.)
|
|
Kerwin, Robert.
|
| ISBN |
0203213254 |
|
9780203213254 |
|
1853179256 |
|
9781853179259 |
|
1280019271 |
|
9781280019272 |
|
9781135373689 |
|
113537368X |
|
9781135373634 |
|
1135373639 |
|
9781135373672 |
|
1135373671 |
|
